Literature DB >> 19596783

The multiple endocrine neoplasia type 1 (MEN1) tumor suppressor regulates peroxisome proliferator-activated receptor gamma-dependent adipocyte differentiation.

Koen M A Dreijerink1, Radhika A Varier, Olivier van Beekum, Ellen H Jeninga, Jo W M Höppener, Cornelis J M Lips, J Alain Kummer, Eric Kalkhoven, H T Marc Timmers.   

Abstract

Menin, the product of the MEN1 (multiple endocrine neoplasia type 1) tumor suppressor gene, is involved in activation of gene transcription as part of an MLL1 (mixed-lineage leukemia 1)/MLL2 (KMT2A/B)-containing protein complex which harbors methyltransferase activity for lysine 4 of histone H3 (H3K4). As MEN1 patients frequently develop lipomas and peroxisome proliferator-activated receptor gamma (PPARgamma) is expressed in several MEN1-related tumor types, we investigated regulation of PPARgamma activity by menin. We found that menin is required for adipocyte differentiation of murine 3T3-L1 cells and PPARgamma-expressing mouse embryonic fibroblasts. Menin augments PPARgamma target gene expression through recruitment of H3K4 methyltransferase activity. Menin interacts directly with the activation function 2 transcription activation domain of PPARgamma in a ligand-independent fashion. Ligand-dependent coactivation, however, is dependent on the LXXLL motif of menin and the intact helix 12 of PPARgamma. We propose that menin is an important factor in PPARgamma-mediated adipogenesis and that loss of PPARgamma function may contribute to lipoma development in MEN1 patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19596783      PMCID: PMC2738285          DOI: 10.1128/MCB.01001-08

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  55 in total

1.  Identification of a ubiquitin-protein ligase subunit within the CCR4-NOT transcription repressor complex.

Authors:  Thomas K Albert; Hiroyuki Hanzawa; Yvonne I A Legtenberg; Marjolein J de Ruwe; Fiona A J van den Heuvel; Martine A Collart; Rolf Boelens; H Th Marc Timmers
Journal:  EMBO J       Date:  2002-02-01       Impact factor: 11.598

2.  A dominant-negative peroxisome proliferator-activated receptor gamma (PPARgamma) mutant is a constitutive repressor and inhibits PPARgamma-mediated adipogenesis.

Authors:  M Gurnell; J M Wentworth; M Agostini; M Adams; T N Collingwood; C Provenzano; P O Browne; O Rajanayagam; T P Burris; J W Schwabe; M A Lazar; V K Chatterjee
Journal:  J Biol Chem       Date:  2000-02-25       Impact factor: 5.157

3.  Pioglitazone inhibits growth of carcinoid cells and promotes TRAIL-induced apoptosis by induction of p21waf1/cip1.

Authors:  R Göke; A Göke; B Göke; W S El-Deiry; Y Chen
Journal:  Digestion       Date:  2001       Impact factor: 3.216

4.  Transcription coactivator TRAP220 is required for PPAR gamma 2-stimulated adipogenesis.

Authors:  Kai Ge; Mohamed Guermah; Chao-Xing Yuan; Mitsuhiro Ito; Annika E Wallberg; Bruce M Spiegelman; Robert G Roeder
Journal:  Nature       Date:  2002-05-30       Impact factor: 49.962

5.  Role of PPARgamma in regulating a cascade expression of cyclin-dependent kinase inhibitors, p18(INK4c) and p21(Waf1/Cip1), during adipogenesis.

Authors:  R F Morrison; S R Farmer
Journal:  J Biol Chem       Date:  1999-06-11       Impact factor: 5.157

Review 6.  Guidelines for diagnosis and therapy of MEN type 1 and type 2.

Authors:  M L Brandi; R F Gagel; A Angeli; J P Bilezikian; P Beck-Peccoz; C Bordi; B Conte-Devolx; A Falchetti; R G Gheri; A Libroia; C J Lips; G Lombardi; M Mannelli; F Pacini; B A Ponder; F Raue; B Skogseid; G Tamburrano; R V Thakker; N W Thompson; P Tomassetti; F Tonelli; S A Wells; S J Marx
Journal:  J Clin Endocrinol Metab       Date:  2001-12       Impact factor: 5.958

7.  Regulation of transcription by a protein methyltransferase.

Authors:  D Chen; H Ma; H Hong; S S Koh; S M Huang; B T Schurter; D W Aswad; M R Stallcup
Journal:  Science       Date:  1999-06-25       Impact factor: 47.728

8.  Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in normal human pancreatic islet cells.

Authors:  M Dubois; F Pattou; J Kerr-Conte; V Gmyr; B Vandewalle; P Desreumaux; J Auwerx; K Schoonjans; J Lefebvre
Journal:  Diabetologia       Date:  2000-09       Impact factor: 10.122

9.  Enhancement of the aquaporin adipose gene expression by a peroxisome proliferator-activated receptor gamma.

Authors:  K Kishida; I Shimomura; H Nishizawa; N Maeda; H Kuriyama; H Kondo; M Matsuda; H Nagaretani; N Ouchi; K Hotta; S Kihara; T Kadowaki; T Funahashi; Y Matsuzawa
Journal:  J Biol Chem       Date:  2001-10-25       Impact factor: 5.157

10.  PPAR-gamma receptor ligands: novel therapy for pituitary adenomas.

Authors:  Anthony P Heaney; Manory Fernando; Shlomo Melmed
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

View more
  26 in total

Review 1.  LKB1 signaling in advancing cell differentiation.

Authors:  Lina Udd; Tomi P Mäkelä
Journal:  Fam Cancer       Date:  2011-09       Impact factor: 2.375

2.  Menin induces endodermal differentiation in aggregated P19 stem cells by modulating the retinoic acid receptors.

Authors:  Jyotshnabala Kanungo; Settara C Chandrasekharappa
Journal:  Mol Cell Biochem       Date:  2011-08-11       Impact factor: 3.396

3.  Concomitant deletions of tumor suppressor genes MEN1 and AIP are essential for the pathogenesis of the brown fat tumor hibernoma.

Authors:  Karolin H Nord; Linda Magnusson; Margareth Isaksson; Jenny Nilsson; Henrik Lilljebjörn; Henryk A Domanski; Lars-Gunnar Kindblom; Nils Mandahl; Fredrik Mertens
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-15       Impact factor: 11.205

4.  Menin represses tumorigenesis via repressing cell proliferation.

Authors:  Ting Wu; Xianxin Hua
Journal:  Am J Cancer Res       Date:  2011-05-16       Impact factor: 6.166

5.  Menin is required for optimal processing of the microRNA let-7a.

Authors:  Buddha Gurung; Abdul Bari Muhammad; Xianxin Hua
Journal:  J Biol Chem       Date:  2014-02-21       Impact factor: 5.157

6.  Enhancer-Mediated Oncogenic Function of the Menin Tumor Suppressor in Breast Cancer.

Authors:  Koen M A Dreijerink; Anna C Groner; Erica S M Vos; Alba Font-Tello; Lei Gu; David Chi; Jaime Reyes; Jennifer Cook; Elgene Lim; Charles Y Lin; Wouter de Laat; Prakash K Rao; Henry W Long; Myles Brown
Journal:  Cell Rep       Date:  2017-03-07       Impact factor: 9.423

Review 7.  Twenty years of menin: emerging opportunities for restoration of transcriptional regulation in MEN1.

Authors:  Koen M A Dreijerink; H T Marc Timmers; Myles Brown
Journal:  Endocr Relat Cancer       Date:  2017-08-15       Impact factor: 5.678

Review 8.  Menin: a scaffold protein that controls gene expression and cell signaling.

Authors:  Smita Matkar; Austin Thiel; Xianxin Hua
Journal:  Trends Biochem Sci       Date:  2013-07-10       Impact factor: 13.807

Review 9.  Menin and bone metabolism.

Authors:  Hiroshi Kaji
Journal:  J Bone Miner Metab       Date:  2012-04-28       Impact factor: 2.626

10.  Antisense transcript long noncoding RNA (lncRNA) HOTAIR is transcriptionally induced by estradiol.

Authors:  Arunoday Bhan; Imran Hussain; Khairul I Ansari; Sahba Kasiri; Aarti Bashyal; Subhrangsu S Mandal
Journal:  J Mol Biol       Date:  2013-01-31       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.